-
Pioneering Gene Medicine
Delivering Lifelong Cures -
Pioneering Gene Medicine
Delivering Lifelong Cures -
Pioneering Gene Medicine
Delivering Lifelong Cures
Science
-
Genome Editing PlatformNovel Genome Editing Toolbox - YTDE & YolBE
AI-Powered Discovery Platform using Metagenomics Data
Disease
-
Familial Hypercholesterolemia (FH)
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by high levels of cholesterol in the blood, leading to an increased risk of heart disease.
Read More
-
Hereditary Transthyretin Amyloidosis (ATTR)
Hereditary Transthyretin Amyloidosis (ATTR) is a fatal disease characterized by the buildup of abnormal proteins in different organs.
Read More
NEWS
-
Mar 21, 2025
YolTech Therapeutics Announces GMP Manufacturing Facility Expansion to Support Gene Editing Therapy Commercial ManufacturingRead More
-
Mar 11, 2025
YolTech Therapeutics Announces Positive Clinical Results for YOLT-201, an Investigational In Vivo Gene Editing Therapy for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Read More
-
Feb 25, 2025
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)Read More
PIONEERING TOMORROW'S HEALTH
A World-Class Biotech Advancing Well-being and Empowering Our Team.
